120 related articles for article (PubMed ID: 21218565)
21. Regional cerebral glucose metabolism and anxiety symptoms in bipolar depression: effects of levothyroxine.
Bauer M; Berman SM; Schlagenhauf F; Voytek B; Rasgon N; Mandelkern MA; Whybrow PC; London ED
Psychiatry Res; 2010 Jan; 181(1):71-6. PubMed ID: 19962861
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of intravenous citalopram compared with oral citalopram for severe depression. Safety and efficacy data from a double-blind, double-dummy trial.
Guelfi JD; Strub N; Loft H
J Affect Disord; 2000 Jun; 58(3):201-9. PubMed ID: 10802128
[TBL] [Abstract][Full Text] [Related]
23. Brain glucose metabolism during non-rapid eye movement sleep in major depression. A positron emission tomography study.
Ho AP; Gillin JC; Buchsbaum MS; Wu JC; Abel L; Bunney WE
Arch Gen Psychiatry; 1996 Jul; 53(7):645-52. PubMed ID: 8660131
[TBL] [Abstract][Full Text] [Related]
24. Glucose metabolic response to total sleep deprivation, recovery sleep, and acute antidepressant treatment as functional neuroanatomic correlates of treatment outcome in geriatric depression.
Smith GS; Reynolds CF; Houck PR; Dew MA; Ma Y; Mulsant BH; Pollock BG
Am J Geriatr Psychiatry; 2002; 10(5):561-7. PubMed ID: 12213690
[TBL] [Abstract][Full Text] [Related]
25. Regional brain metabolism and treatment response in panic disorder patients: an [18F]FDG-PET study.
Kang EH; Park JE; Lee KH; Cho YS; Kim JJ; Yu BH
Neuropsychobiology; 2012; 66(2):106-11. PubMed ID: 22814210
[TBL] [Abstract][Full Text] [Related]
26. Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram.
Andersen G; Vestergaard K; Lauritzen L
Stroke; 1994 Jun; 25(6):1099-104. PubMed ID: 8202964
[TBL] [Abstract][Full Text] [Related]
27. Alterations in regional cerebral glucose metabolism across waking and non-rapid eye movement sleep in depression.
Nofzinger EA; Buysse DJ; Germain A; Price JC; Meltzer CC; Miewald JM; Kupfer DJ
Arch Gen Psychiatry; 2005 Apr; 62(4):387-96. PubMed ID: 15809406
[TBL] [Abstract][Full Text] [Related]
28. Molecular imaging of beta-amyloid deposition in late-life depression.
Smith GS; Kuwabara H; Nandi A; Gould NF; Nassery N; Savonenko A; Joo JH; Kraut M; Brasic J; Holt DP; Hall AW; Mathews WB; Dannals RF; Avramopoulos D; Workman CI
Neurobiol Aging; 2021 May; 101():85-93. PubMed ID: 33592548
[TBL] [Abstract][Full Text] [Related]
29. Glucose metabolism in the insula and cingulate is affected by systemic inflammation in humans.
Hannestad J; Subramanyam K; Dellagioia N; Planeta-Wilson B; Weinzimmer D; Pittman B; Carson RE
J Nucl Med; 2012 Apr; 53(4):601-7. PubMed ID: 22414635
[TBL] [Abstract][Full Text] [Related]
30. A double-blind double-dummy study of citalopram comparing infusion versus oral administration.
Baumann P; Nil R; Bertschy G; Jecker A; Brändli H; Morand J; Kasas A; Vuagniaux O; Ramseier F
J Affect Disord; 1998 Jun; 49(3):203-10. PubMed ID: 9629950
[TBL] [Abstract][Full Text] [Related]
31. Short-term effects of escitalopram on regional brain function in first-episode drug-naive patients with major depressive disorder assessed by resting-state functional magnetic resonance imaging.
Wang L; Li K; Zhang Q; Zeng Y; Dai W; Su Y; Wang G; Tan Y; Jin Z; Yu X; Si T
Psychol Med; 2014 May; 44(7):1417-26. PubMed ID: 23942213
[TBL] [Abstract][Full Text] [Related]
32. Levothyroxine effects on depressive symptoms and limbic glucose metabolism in bipolar disorder: a randomized, placebo-controlled positron emission tomography study.
Bauer M; Berman S; Stamm T; Plotkin M; Adli M; Pilhatsch M; London ED; Hellemann GS; Whybrow PC; Schlagenhauf F
Mol Psychiatry; 2016 Feb; 21(2):229-36. PubMed ID: 25600111
[TBL] [Abstract][Full Text] [Related]
33. Cerebral glucose metabolism abnormalities in patients with major depressive symptoms in pre-dialytic chronic kidney disease: statistical parametric mapping analysis of F-18-FDG PET, a preliminary study.
Song SH; Kim IJ; Kim SJ; Kwak IS; Kim YK
Psychiatry Clin Neurosci; 2008 Oct; 62(5):554-61. PubMed ID: 18950375
[TBL] [Abstract][Full Text] [Related]
34. Changes in cerebral glucose metabolism in patients with posttraumatic cognitive impairment after memantine therapy: a preliminary study.
Kim YW; Shin JC; An YS
Ann Nucl Med; 2010 Jun; 24(5):363-9. PubMed ID: 20237871
[TBL] [Abstract][Full Text] [Related]
35. [Safety and efficacy of oral escitalopram as continuation treatment of intravenous citalopram, in patients with major depressive disorder--the navigade switch study].
Schmitt L; Arbus C; Tonnoir B
Encephale; 2006; 32(2 Pt 1):270-7. PubMed ID: 16910629
[TBL] [Abstract][Full Text] [Related]
36. Regional effects of lamotrigine on cerebral glucose metabolism in idiopathic generalized epilepsy.
Joo EY; Tae WS; Hong SB
Arch Neurol; 2006 Sep; 63(9):1282-6. PubMed ID: 16966506
[TBL] [Abstract][Full Text] [Related]
37. [Effect of needling at waiguan (SJ5) on brain glucose metabolism in patients with cerebral infarction].
Liu ET; Wang SX; Huang Y; Lai XS; Tang CZ; Cui SY
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Oct; 33(10):1345-51. PubMed ID: 24432677
[TBL] [Abstract][Full Text] [Related]
38. Spatiotemporal brain activation pattern following acute citalopram challenge is dose dependent and associated with neuroticism: A human phMRI study.
Edes AE; McKie S; Szabo E; Kokonyei G; Pap D; Zsombok T; Hullam G; Gonda X; Kozak LR; McFarquhar M; Anderson IM; Deakin JFW; Bagdy G; Juhasz G
Neuropharmacology; 2020 Jun; 170():107807. PubMed ID: 31593709
[TBL] [Abstract][Full Text] [Related]
39. Therapy of interferon-induced depression in chronic hepatitis C with citalopram: a randomised, double-blind, placebo-controlled study.
Kraus MR; Schäfer A; Schöttker K; Keicher C; Weissbrich B; Hofbauer I; Scheurlen M
Gut; 2008 Apr; 57(4):531-6. PubMed ID: 18079286
[TBL] [Abstract][Full Text] [Related]
40. Neural correlates of citalopram and placebo response in acute bipolar depression: A randomized trial.
Sretavan Wong K; Migó M; Dougherty DD; Ghaemi SN
J Psychiatr Res; 2021 Jun; 138():463-466. PubMed ID: 33965734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
